Add BrightSurf on Google Email

University of Pennsylvania School of Medicine


Genome-wide screen of learning in zebrafish identifies enzyme important in neural circuit

A genome-wide screen of zebrafish identified an enzyme, pregnancy-associated plasma protein-aa (pappaa), that promotes learning and memory by increasing IGF availability to neurons. The study's findings have implications for understanding human neuropsychiatric disorders, such as schizophrenia, autism, and obsessive-compulsive disorder.

Twitter chatter predicts health insurance marketplace enrollment, Penn study shows

A study by researchers at the University of Pennsylvania School of Medicine found a significant correlation between Twitter sentiment and health insurance marketplace enrollment. The analysis of 977,303 tweets revealed that a 0.10 increase in positive sentiment was associated with a 9% increase in enrollment.

SourceUniversity of Pennsylvania School of Medicine·JournalJournal of Medical Internet Research·DateMar 4, 2015

Penn study: OTC medications and supplements are most common causes of drug-induced liver failure

A new Penn study reveals that over-the-counter medications and dietary supplements are the leading causes of drug-induced liver failure, not prescription drugs. The research analyzed data from an integrated healthcare system in Northern California and found that acetaminophen and herbal supplements were responsible for nearly half of a...

Strong connection between violence and mental illness during Guatemala Civil War

Research suggests that those who experienced violence during the Guatemala Civil War are four times more likely to suffer from PTSD and alcohol-related disorders. The study, led by Victor D. Puac-Polanco and Charles C. Branas, found significant mental health problems among Guatemalans who witnessed or experienced violent events.

SourceUniversity of Pennsylvania School of Medicine·JournalAmerican Journal of Public Health·DateFeb 26, 2015

Development of personalized cellular therapy for brain cancer

A preclinical study by the University of Pennsylvania School of Medicine found engineered T cells to be both safe and effective at controlling tumor growth in mice with glioblastoma. The CAR T cells target a mutation in the epidermal growth factor receptor protein called EGFRvIII, found on about 30% of glioblastoma patients' tumor cells.

SourceUniversity of Pennsylvania School of Medicine·JournalScience Translational Medicine·DateFeb 18, 2015

Penn Medicine: Brain activity can predict increased fat intake following sleep deprivation

A new study found that sleep-deprived individuals consume more fat and less carbohydrates, while displaying increased connectivity in the salience network, which is linked to emotional responses and bodily sensations. This unique approach examines changes in brain activity's impact on eating behavior following sleep deprivation.

SourceUniversity of Pennsylvania School of Medicine·JournalScientific Reports·DateFeb 12, 2015

Immune biomarkers help predict early death, complications in HIV patients with TB

Researchers identified key immune biomarkers that can help distinguish between HIV patients who experience life-threatening complications and those who fare well on treatment. The findings suggest that personalized approaches may be necessary for these patients, as a one-size-fits-all approach could worsen outcomes.

SourceUniversity of Pennsylvania School of Medicine·JournalThe Lancet Infectious Diseases·DateFeb 9, 2015

Islet cell transplantation restores type 1 diabetics' blood sugar defense mechanisms

Researchers at the University of Pennsylvania School of Medicine have successfully restored type 1 diabetics' ability to recognize low blood sugar levels after receiving islet cell transplantation. The treatment has nearly abolished time spent in a hypoglycemic state and improved response to experimental insulin-induced hypoglycemia.

New technology directly reprograms skin fibroblasts for a new role

Researchers at the University of Pennsylvania School of Medicine have discovered a way to directly reprogram skin fibroblasts into functional melanocytes, the body's pigment-producing cells. This technique has significant implications for developing new cell-based treatments for skin diseases and screening strategies for melanoma.

SourceUniversity of Pennsylvania School of Medicine·JournalNature Communications·DateDec 16, 2014

Simeprevir-based therapy offers cost-effective alternative in treatment of hepatitis C

A new study has shown that a simeprevir-based therapy is as effective as the standard of care in treating chronic Hepatitis C virus infection, with fewer adverse events. The study found that simeprevir was well-tolerated and could be a viable alternative for patients who cannot access or afford newer treatment options.

SourceUniversity of Pennsylvania School of Medicine·JournalThe Lancet Infectious Diseases·DateDec 9, 2014

No increase in patient deaths or readmissions following restrictions to residents' hours

A recent study published in JAMA found that restricting residents' work hours to 16-24 hours per shift had no impact on patient deaths or readmissions. The researchers analyzed nearly 6.4 million Medicare patient hospital admissions between 2009 and 2012, but found no relative changes in mortality rates during this time period.

Brain activity after smokers quit predicts chances of relapsing, Penn study suggests

A Penn Medicine study suggests that disruptions in brain memory-related activity after quitting can identify smokers at risk of relapsing. Smokers who failed to quit had decreased activity in the left dorsolateral prefrontal cortex and reduced suppression of activation in the posterior cingulate cortex, indicating a higher chance of re...

SourceUniversity of Pennsylvania School of Medicine·JournalNeuropsychopharmacology·DateDec 3, 2014

Physicians prescribe less brand name drugs when EHR default settings show generics first

A study found that programming electronic health records to make generic drugs the default choice increases generic medication prescribing rates, leading to cost savings and reduced healthcare spending. The intervention was effective in both ambulatory clinics and did not require additional effort from physicians.

SourceUniversity of Pennsylvania School of Medicine·JournalAnnals of Internal Medicine·DateNov 17, 2014

Olaparib shows success in tumor response rate for patients with BRCA-related cancers

A phase II study led by the University of Pennsylvania School of Medicine found olaparib produced a 26% overall tumor response rate in patients with advanced cancers associated with BRCA1 and BRCA2 mutations. The treatment showed improved survival rates for patients with ovarian, breast, pancreatic, and prostate cancers.

SourceUniversity of Pennsylvania School of Medicine·JournalJournal of Clinical Oncology·DateNov 6, 2014

Medicare may need to expand options for behavioral weight loss counseling in primary care

A systematic review found that high-quality randomized controlled trials on behavioral weight loss counseling in primary care settings are limited, with only two studies identifying effective interventions producing an average weight loss of at least five percent. The review highlights the need for further research to evaluate the effe...